🇺🇸 FDA
Patent

US 6956060

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

expired A61KA61K31/135A61K31/195

Quick answer

US patent 6956060 (Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Oct 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/135, A61K31/195, A61K31/205, A61K31/215